Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alzheimer’s Drugs Take Baby Steps Toward Brighter Future

Executive Summary

Anti-beta amyloid antibodies from Lilly, Biogen Idec and Roche took center stage at the recent Alzheimer’s Association International Congress, but as a new PhRMA analysis shows, getting to the development finish line is rare – with 30 failures for every one success.

Advertisement

Related Content

Full Monty On Pfizer’s Failed 5-HT6 Alzheimer’s Drug Leaves Hope For Class
Alzheon Revives Failed Alzheimer's Drug With Genetic Subtype Approach
Daewha Sees Promise In Herbal-Derived Alzheimer’s Candidate
Axovant Builds A Case For GSK’s 5-HT6 Castoff In Alzheimer’s
FDA Responds to Nagging Questions About “Lagging” Drug Review Divisions
Biogen Idec Finalizes Phase III Plans For Aducanumab In Alzheimer’s
Observational Studies Reveal Commonalities Across Neurodegenerative Disorders Like Parkinson’s And Alzheimer’s
FDA Draft Guidance On Drug Development For Early Alzheimer's A Call For Action On Biomarkers
Efficacy Signal For Lilly’s Solanezumab Stirs The Alzheimer’s Pot

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS057018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel